Pacific Edge says US medical and legal tides have turned in its favour

Pacific Edge says US medical and legal tides have turned in its favour
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge is confident its newly announced $20 million capital raise, combined with new research results and professional validation, will keep it in the bladder cancer testing game.Chief executive Peter Meintjes says a clinical endorsement from the American Urological Association (AUA) should give it the medical and legal clout to regain Medicare coverage for its bladder cancer tests in the US.The dual NZX and ASX-listed medical technology company reported a net loss of $29.9m in the 12 months to March 31, 2025, compared with $29.5m in the...

More Markets

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025
Smart CEO Anna Scott resigns
Markets

Smart CEO Anna Scott resigns

Anna Scott will take up her new role on October 1.

Staff reporters 02 Jul 2025
Forsyth Barr highlights 'hidden gem' at Ebos
Markets

Forsyth Barr highlights 'hidden gem' at Ebos

Both businesses were part of its A$1.16b LifeHealthcare acquisition.

Rebecca Howard 02 Jul 2025